UPLOAD Filing
Can-Fite BioPharma Ltd.
Date: July 22, 2025 · CIK: 0001536196 · Accession: 0000000000-25-007680
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-36203
Letter
Re: Can-Fite BioPharma Ltd. Form 20-F for Fiscal Year Ended December 31, 2024 File No. 001-36203 Dear Motti Farbstein:
July 22, 2025
Motti Farbstein Chief Executive Officer and Chief Financial Officer Can-Fite BioPharma Ltd. 26 Ben Gurion St, Ramat Gan 5257346 Israel
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 22, 2025 Motti Farbstein Chief Executive Officer and Chief Financial Officer Can-Fite BioPharma Ltd. 26 Ben Gurion St, Ramat Gan 5257346 Israel Re: Can-Fite BioPharma Ltd. Form 20-F for Fiscal Year Ended December 31, 2024 File No. 001-36203 Dear Motti Farbstein: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>